APA (7th ed.) Citation

How, S. H., Tho, L. M., Liam, C. K., Hasbullah, H. H., Ho, G. F., Muhammad Nor, I., . . . Soon, S. Y. (2022). Programmed death‐ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non‐small‐cell lung cancer in a resource‐limited country. Thoracic cancer, 13(11), 1676-1683. https://doi.org/10.1111/1759-7714.14442

Chicago Style (17th ed.) Citation

How, Soon Hin, et al. "Programmed Death‐ligand 1 Expression and Use of Immune Checkpoint Inhibitors Among Patients with Advanced Non‐small‐cell Lung Cancer in a Resource‐limited Country." Thoracic Cancer 13, no. 11 (2022): 1676-1683. https://doi.org/10.1111/1759-7714.14442.

MLA (9th ed.) Citation

How, Soon Hin, et al. "Programmed Death‐ligand 1 Expression and Use of Immune Checkpoint Inhibitors Among Patients with Advanced Non‐small‐cell Lung Cancer in a Resource‐limited Country." Thoracic Cancer, vol. 13, no. 11, 2022, pp. 1676-1683, https://doi.org/10.1111/1759-7714.14442.